Flamma

Pharmaceutical ManufacturingLombardy, Italy201-500 Employees

Flamma is a global contract development and manufacturing organization focused on chemistry-driven small molecule APIs, starting materials, and advanced intermediates, offering services from early-stage process development through commercial production. It maintains an integrated network with manufacturing in Italy and strategic facilities in the United States and China, including FDA-inspected cGMP sites in Italy and the United States and a fully owned facility in Dalian, supporting a resilient global supply chain for innovator customers. In the U.S., Flamma USA provides early-stage development capabilities, including high-potency API and controlled-substance handling, complementing its China operations to accelerate timelines and optimize costs.

Founded on decades of experience, Flamma presents itself as a CDMO with recognized strengths in expertise, reliability, capabilities, quality, service, and compatibility, seeking to guide complex small-molecule programs from concept to commerce. The company is advancing its global infrastructure, including a new cGMP plant in Dalian as part of a roughly $200 million expansion aimed at increasing capacity and long-term supply security, and is pursuing digital modernization through centralized electronic lab notebooks to improve data visibility across sites. Recent developments include industry recognition as a 2025 CDMO Leadership Award winner and the appointment of Giorgio Bertolini as General Manager for Italy, underscoring growth of its European footprint.

Sign up for free to view info

Email Format Employee directory